Related Experiment Videos
Purification and characterization of malate dehydrogenase from Cryptococcus neoformans
Y A Mahmoud1, S M el Souod, W G Niehaus
1Department of Biochemistry and Anaerobic Microbiology, Virginia Polytechnic Institute and State University, Blacksburg 24061, USA.
Archives of Biochemistry and Biophysics
|September 10, 1995
Summary
Researchers purified NAD-dependent malate dehydrogenase from the opportunistic pathogen Cryptococcus neoformans. This enzyme showed unique inhibition by zinc and heparin, suggesting novel regulatory mechanisms in this yeast.
Area of Science:
- Biochemistry
- Enzymology
- Medical Mycology
Background:
- Cryptococcus neoformans is an opportunistic fungal pathogen affecting AIDS patients.
- Malate dehydrogenases are crucial enzymes in cellular metabolism.
- Understanding enzyme kinetics and inhibition provides insights into pathogen biology.
Purpose of the Study:
- To purify and characterize the NAD-dependent malate dehydrogenase from Cryptococcus neoformans.
- To elucidate the kinetic mechanism and inhibition patterns of the enzyme.
- To investigate unique inhibitory properties, particularly by heparin.
Main Methods:
- Enzyme purification from Cryptococcus neoformans.
- Kinetic assays to determine substrate inhibition and product inhibition.
- Inhibition studies using zinc ions and heparin of various molecular weights.
Main Results:
- The purified enzyme is a dimer (35 kDa subunits) exhibiting uncompetitive oxaloacetate inhibition.
- An ordered sequential kinetic mechanism was identified, with NAD+ binding first.
- Unique inhibition by zinc (Ki = 30 microM vs. malate) and heparin (Ki = 0.35 microM vs. NAD+ or malate) was observed, with heparin of different molecular weights showing equal efficacy.
Conclusions:
- The malate dehydrogenase from C. neoformans shares typical features with other mitochondrial MDHs but possesses unique inhibitory characteristics.
- Heparin's potent inhibition suggests a potential role in enzyme regulation or a novel interaction mechanism.
- Further studies are warranted to explore the implications of heparin binding for enzyme function and potential therapeutic targets.